← All trials
NCT06498115
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2024
- Primary completion
- Sep 30, 2024
- Completion date
- Dec 31, 2024
- First posted
- Jul 12, 2024
- Last posted
- Jul 12, 2024
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Third People's Hospital of BengbuLead sponsor
- The Third People's Hospital of BengbuSponsor investigator
- The Third People's Hospital of BengbuOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.